Article | May 27, 2020

The Cost Of Failing To Protect Your Final Biopharmaceutical Product

By Graeme Proctor

SciPure

During downstream processing, the value of a product increases with every unit step of the operation, designed to both remove impurities and concentrate the biologically active component.

Each of these unit operations involves a significant cost to the biopharmaceutical manufacturer. From cell harvesting and clarification, through affinity chromatography, buffer exchange, cation exchange chromatography, viral reduction, anion exchange chromatography, viral inactivation, concentration, sterile filtration and filling, value is added and is incremental.

Cost breakdown

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: